KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Free Cash Flow (2016 - 2026)

Novartis Ag's Free Cash Flow history spans 16 years, with the latest figure at $346.0 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 36.22% to $346.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.3 billion, a 38.07% decrease, with the full-year FY2025 number at $17.6 billion, up 8.26% from a year prior.
  • Free Cash Flow hit $346.0 million in Q1 2026 for Novartis Ag, down from $609.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for NVS hit a ceiling of $7.7 billion in Q4 2024 and a floor of $168.0 million in Q1 2023.
  • Historically, Free Cash Flow has averaged $2.5 billion across 5 years, with a median of $354.0 million in 2025.
  • The widest YoY moves for Free Cash Flow: up 36.22% in 2025, down 92.09% in 2025.
  • Tracing NVS's Free Cash Flow over 5 years: stood at $5.7 billion in 2022, then grew by 21.52% to $6.9 billion in 2023, then grew by 10.94% to $7.7 billion in 2024, then crashed by 92.09% to $609.0 million in 2025, then crashed by 43.19% to $346.0 million in 2026.
  • Business Quant data shows Free Cash Flow for NVS at $346.0 million in Q1 2026, $609.0 million in Q4 2025, and $354.0 million in Q3 2025.